A. Fleishman
Impact in
- Hematology top 5%
- Erythropoietin and Anemia Treatment
- Iron Metabolism and Disorders
- Multiple Myeloma Research and Treatments
- Biochemistry top 10%
- Blood transfusion and management
Papers in
- Hematology 11
- Erythropoietin and Anemia Treatment 10
- Chronic Myeloid Leukemia Treatments 1
-
- Biosimilars and Bioanalytical Methods 3
- Co-authors
- John A. Glaspy (7 shared papers)Alan Colowick (3 shared papers)Matthew B. Rettig (1 shared paper)Stanisław Krajewski (1 shared paper)Yiping Tu (1 shared paper)Alan Lichtenstein (1 shared paper)John C. Reed (1 shared paper)Jeremy M. G. Taylor (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)Blood (1 paper)Cardiology and Therapy (1 paper)Journal of Thoracic Oncology (1 paper)The Journal of Infectious Diseases (1 paper)
- Partner nations
- United StatesAustriaBelgium
In The Last Decade
A. Fleishman
15 papers receiving 529 citations
Peers
Comparison fields: 5 of 66
- Hematology 307
- Biochemistry 55
- Oncology 168
- Genetics 41
- Nephrology 18
Countries citing papers authored by A. Fleishman
This map shows the geographic impact of A. Fleishman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Fleishman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Fleishman more than expected).
Fields of papers citing papers by A. Fleishman
This network shows the impact of papers produced by A. Fleishman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Fleishman. The network helps show where A. Fleishman may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Fleishman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | BCL-X expression in multiple myeloma: possible indicator of chemoresistance. | 1998 | 203 |
| 2 | 2009 | 110 | |
| 3 | 2001 | 73 | |
| 4 | 2003 | 71 | |
| 5 | 2004 | 34 | |
| 6 | 2000 | 19 | |
| 7 | 2001 | 11 | |
| 8 | 2007 | 10 | |
| 9 | 2020 | 8 | |
| 10 | 2018 | 3 | |
| 11 | 2007 | 3 | |
| 12 | 2012 | 2 | |
| 13 | 2007 | 1 | |
| 14 | 2017 | 1 | |
| 15 | 2010 | 1 |
About A. Fleishman
A. Fleishman is a scholar working on Hematology, Immunology, Infectious Diseases, Genetics and Pediatrics, Perinatology and Child Health, having authored 15 papers that have together received 550 indexed citations. Recurring topics across this work include Erythropoietin and Anemia Treatment (10 papers), Biosimilars and Bioanalytical Methods (3 papers), Hemoglobinopathies and Related Disorders (2 papers), Blood transfusion and management (2 papers), HIV/AIDS drug development and treatment (2 papers), Pharmacological Effects and Toxicity Studies (2 papers), Pharmacogenetics and Drug Metabolism (1 paper) and Chronic Myeloid Leukemia Treatments (1 paper). The work is most often cited by research in Hematology (307 citations), Biochemistry (55 citations), Oncology (168 citations), Genetics (41 citations) and Nephrology (18 citations). A. Fleishman has collaborated with scholars based in United States, Austria and Belgium. Frequent co-authors include John A. Glaspy, Alan Colowick, Matthew B. Rettig, Stanisław Krajewski, Yiping Tu, Alan Lichtenstein, John C. Reed, Jeremy M. G. Taylor, James Berenson and Judith Weisz. Their work appears in journals such as Journal of Clinical Oncology, Blood, Cardiology and Therapy, Journal of Thoracic Oncology and The Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.